Latest Anthrax Stories
ANNAPOLIS, Md., April 7, 2014 /PRNewswire/ -- PharmAthene, Inc.
ANNAPOLIS, Md., April 1, 2014 /PRNewswire/ -- PharmAthene, Inc.
PINE BROOK, N.J., March 10, 2014 /PRNewswire/ -- Elusys Therapeutics, Inc.
A new naming system proposed by one Virginia Tech scientist proposes moving beyond the current biological naming system and supplementing it with a new classification method based on an organism’s genome sequence.
Over 400 subjects participating in phase 3 studies PINE BROOK, N.J., Feb. 5, 2014 /PRNewswire/ -- Elusys Therapeutics, Inc.
Grime Busters and Amazing! NOK OUT™ is on a mission to educate consumers and eradicate disease-causing organisms.
HONOLULU, Feb. 4, 2014 /PRNewswire/ -- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded Hawaii Biotech, Inc.
The ability to remediate buildings following a weaponized biological attack may have been achieved with AsepticSure® SAN FRANCISCO, Jan.
From a zebra carcass on the plains of Namibia in Southern Africa, an international team of researchers has discovered a new, unusually large virus (or bacteriophage) that infects the bacterium that causes anthrax.
Milestone Achieved under $9.4 Million NIAID Cooperative Grant PRINCETON, N.J., Jan. 15, 2014 /PRNewswire/ -- Soligenix, Inc.
Bacillus anthracis is a Gram-positive spore-forming, rod-shaped bacterium, with a width of 1-1.2Âµm and a length of 3-5Âµm. It can grow in aerobic or anaerobic conditions. It is the only known bacterium to synthesize a protein capsule and the only pathogenic bacterium to carry its own adenylyl cyclase virulence factor. They form oval spores located centrally in a non-swollen sporangium. These spores are highly resilient and can survive extreme temperatures, low-nutrient environments, and...
- Monstrous in size or character; huge; prodigious; monstrously perverse, savage, cruel, etc.